Santhera Pharmaceuticals Holding AG: Santhera Announces Prel

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Austria , France , United Kingdom , Germany , Spain , Pratteln , Switzerland General , Switzerland , Highbridge , Somerset , United States , Italy , French , America , German , Dennis Riedl , Eva Kalias , Dario Eklund , Shabir Hasham , Chiesi Farmaceutici , Andrew Smith , Santhera Pharmaceuticals , China National Medical Products Administration , Catalyst Pharmaceuticals , Head Investor Relations Communications , Exchange Regulation , European Medicines Agency , Bonds , European Union Summary Of Product Characteristics , Chiesi Group , Santhera Pharmaceuticals Holding Ltd , Exchange Regulation Ltd , Nasdaq , Catalyst Pharmaceuticals Inc , Santhera Pharmaceuticals Holding , National Institute For Health , Announces Preliminary Unaudited , Provides Corporate Update Ahead , Full Report Publication , North America , Drug Evaluation , National Medical Products Administration , National Institute , Care Excellence , Sperogenix Therapeutics , Annual General Meeting , Regulation Ltd , United States Prescribing Information , European Union Summary , Head Investor Relations , Aktien Sie ,